Senseonics announced today that it entered into a strategic partnership with Rimidi to develop a remote patient monitoring ...

Q1 2024 Earnings Call Transcript May 13, 2024 Operator: Good afternoon, everyone, and welcome to the Senseonics First Quarter ...

Senseonics (SENS) stock rose 3% in post-market trading Thursday after it announced a partnership with Rimidi for a remote ...

Senseonics (SENS) announced that its new Eversense Remote Patient Monitoring system for diabetes management would be used ...

Senseonics, in collaboration with its commercial partner, Ascensia Diabetes Care, intends to make the Eversense CGM+RPM solution available to select population health-based systems beginning in the ...

The first fully implantable continuous glucose monitors can now be integrated with insulin pumps as part of an automated insulin delivery system GERMANTOWN, Md. & PARSIPPANY, N.J., April 30, 2024 ...

We look forward to providing Ascensia, our commercial partner, with this exciting program, offering further reason for providers and patients to choose Eversense." Senseonics, in collaboration ...

Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring ...

In this interview, Dr. Fu Wei, Director of Quality Management Department at BGI Genomics talks to AZoMedical about achieving and maintaining ISO/IEC 27001 and BS 10012 certifications. Isaac ...

The Eversense E3 CGM, brought to people by Ascensia Diabetes Care, has been called the “CGM for real life” and Dianne couldn’t agree more. The ability to remove and replace the Eversense transmitter[1 ...